Heparin-induced thrombocytopenia history and symptoms: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:
** High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation
** High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation
** The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin [[glycosaminoglycans]] like [[chondroitin sulfate]] and not to heparin.  
** The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin [[glycosaminoglycans]] like [[chondroitin sulfate]] and not to heparin.  
* The incidence of delayed onset [[HIT]] are less compared to other forms of HIT.


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 15:52, 4 December 2011

WikiDoc Resources for Heparin-induced thrombocytopenia history and symptoms

Articles

Most recent articles on Heparin-induced thrombocytopenia history and symptoms

Most cited articles on Heparin-induced thrombocytopenia history and symptoms

Review articles on Heparin-induced thrombocytopenia history and symptoms

Articles on Heparin-induced thrombocytopenia history and symptoms in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Heparin-induced thrombocytopenia history and symptoms

Images of Heparin-induced thrombocytopenia history and symptoms

Photos of Heparin-induced thrombocytopenia history and symptoms

Podcasts & MP3s on Heparin-induced thrombocytopenia history and symptoms

Videos on Heparin-induced thrombocytopenia history and symptoms

Evidence Based Medicine

Cochrane Collaboration on Heparin-induced thrombocytopenia history and symptoms

Bandolier on Heparin-induced thrombocytopenia history and symptoms

TRIP on Heparin-induced thrombocytopenia history and symptoms

Clinical Trials

Ongoing Trials on Heparin-induced thrombocytopenia history and symptoms at Clinical Trials.gov

Trial results on Heparin-induced thrombocytopenia history and symptoms

Clinical Trials on Heparin-induced thrombocytopenia history and symptoms at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Heparin-induced thrombocytopenia history and symptoms

NICE Guidance on Heparin-induced thrombocytopenia history and symptoms

NHS PRODIGY Guidance

FDA on Heparin-induced thrombocytopenia history and symptoms

CDC on Heparin-induced thrombocytopenia history and symptoms

Books

Books on Heparin-induced thrombocytopenia history and symptoms

News

Heparin-induced thrombocytopenia history and symptoms in the news

Be alerted to news on Heparin-induced thrombocytopenia history and symptoms

News trends on Heparin-induced thrombocytopenia history and symptoms

Commentary

Blogs on Heparin-induced thrombocytopenia history and symptoms

Definitions

Definitions of Heparin-induced thrombocytopenia history and symptoms

Patient Resources / Community

Patient resources on Heparin-induced thrombocytopenia history and symptoms

Discussion groups on Heparin-induced thrombocytopenia history and symptoms

Patient Handouts on Heparin-induced thrombocytopenia history and symptoms

Directions to Hospitals Treating Heparin-induced thrombocytopenia history and symptoms

Risk calculators and risk factors for Heparin-induced thrombocytopenia history and symptoms

Healthcare Provider Resources

Symptoms of Heparin-induced thrombocytopenia history and symptoms

Causes & Risk Factors for Heparin-induced thrombocytopenia history and symptoms

Diagnostic studies for Heparin-induced thrombocytopenia history and symptoms

Treatment of Heparin-induced thrombocytopenia history and symptoms

Continuing Medical Education (CME)

CME Programs on Heparin-induced thrombocytopenia history and symptoms

International

Heparin-induced thrombocytopenia history and symptoms en Espanol

Heparin-induced thrombocytopenia history and symptoms en Francais

Business

Heparin-induced thrombocytopenia history and symptoms in the Marketplace

Patents on Heparin-induced thrombocytopenia history and symptoms

Experimental / Informatics

List of terms related to Heparin-induced thrombocytopenia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. Unlike other immune mediated thrombocytopenia (idiopathic thrombocytopenic purpura), the levels of platelet stays > 20,000 microl, thus frank clinical bleeding is less common in HIT when compared to other conditions, where the platelet may fall below 10,000/ microl.

History

  • Occurs commonly after 5-10 days of initiation of heparin therapy. Onset of HIT after 2 weeks of heparin therapy is uncommon. Earlier onset of HIT is usually seen in patients who have been previously treated with heparin (1-3 months back) and have circulating HIT antibodies in them. In these patients the median time of platelet fall is less than 12 hours after the start of heparin administration
  • Delayed onset HIT:
    • Occurs after heparin has been withdrawn (median time of 14 days after heparin withdrawl)
    • High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation
    • The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin glycosaminoglycans like chondroitin sulfate and not to heparin.
  • The incidence of delayed onset HIT are less compared to other forms of HIT.

Template:WH Template:WS